Data is not available at this time.
Nanjing COSMOS Chemical operates as a specialized manufacturer of daily chemical raw materials, focusing on high-value ingredients for the cosmetics and fragrance industries. The company's core business involves the research, development, and production of sophisticated chemical compounds including sunscreen agents, cosmetic active ingredients, and synthetic fragrance components. Operating within the competitive basic materials sector, COSMOS has established a niche position by supplying essential inputs to global personal care and beauty product manufacturers. The company's strategic focus on research-intensive specialty chemicals differentiates it from commodity chemical producers and creates barriers to entry through technical expertise. With primary sales channels concentrated in Europe and the United States, COSMOS serves international markets that demand high-quality, compliant ingredients for premium consumer products. This export-oriented model positions the company within global supply chains for major cosmetics brands, requiring adherence to stringent international regulatory standards and quality specifications. The company's product portfolio addresses growing consumer demand for advanced skincare and fragrance formulations, particularly in developed markets with strong regulatory frameworks for cosmetic ingredients.
For FY 2024, Nanjing COSMOS Chemical demonstrated solid financial performance with revenue of CNY 2.28 billion and net income of CNY 562 million, translating to a healthy net margin of approximately 24.7%. The company generated robust operating cash flow of CNY 823 million, significantly exceeding its net income, indicating strong cash conversion efficiency. Capital expenditures of CNY 686 million reflect substantial ongoing investments in production capacity and research capabilities, supporting future growth initiatives in the specialty chemicals segment.
The company exhibited strong earnings power with diluted EPS of CNY 1.13, supported by efficient operations in the high-margin specialty chemicals space. Operating cash flow coverage of capital expenditures appears adequate, though the significant capex investment suggests an expansionary phase. The balance between reinvestment and profitability indicates a focus on maintaining technological leadership while delivering shareholder returns through sustainable earnings growth in the competitive ingredients market.
COSMOS maintains a balanced financial position with cash and equivalents of CNY 534 million against total debt of CNY 655 million. The moderate leverage level suggests prudent financial management, with sufficient liquidity to support operations and strategic investments. The company's capital structure appears appropriate for its growth stage in the capital-intensive chemicals industry, providing flexibility for both ongoing operations and potential expansion opportunities in international markets.
The company has implemented a shareholder-friendly dividend policy, distributing CNY 0.21428 per share while maintaining significant reinvestment in the business through substantial capital expenditures. This balanced approach supports both immediate shareholder returns and long-term growth objectives. The strategic focus on high-value cosmetic ingredients positions COSMOS to benefit from global trends in personal care consumption, particularly in developed markets where product sophistication drives demand for specialized chemical inputs.
With a market capitalization of approximately CNY 6.71 billion, the company trades at a P/E ratio of roughly 12 based on FY 2024 earnings. The negative beta of -0.128 suggests low correlation with broader market movements, potentially reflecting the specialized nature of its business. This valuation multiple appears reasonable for a chemical company with strong profitability metrics and exposure to growing end-markets in the cosmetics industry.
COSMOS's strategic advantages include its technical expertise in specialty chemical synthesis and established relationships with international customers. The company's focus on research-driven product development positions it well within evolving regulatory environments for cosmetic ingredients. The outlook remains positive given global demand trends for premium personal care products, though the company faces challenges including raw material price volatility, currency fluctuations, and increasing competition in the specialty chemicals space.
Company financial statementsShenzhen Stock Exchange filings
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |